Post-COVID-19 irritable bowel syndrome: an integrative review
Open Access
- 1 January 2023
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 50, e20233618
Abstract
Introduction: the persistence of long-term symptoms of COVID-19 represents a new challenge for the medical-scientific community, it is the condition called long-term COVID-19. Irritable Bowel Syndrome (IBS) is one of the most common Disorders of the Gut-Brain Interaction and its post-infection development is already validated. According to the Rome IV criteria, it is characterized by the presence of recurrent abdominal pain, on average, at least 1 day a week in the last 3 months with onset of symptoms at least 6 months before diagnosis, associated with 2 or more factors: related to defecation and/or associated with change in stool frequency and/or associated with change in stool form. This study aimed to review data on post-COVID-19 IBS. Methods: this is an integrative review of studies published between January 1, 2020 and April 30, 2023, which presented data on IBS with previously diagnosed COVID-19 disease. The PubMed database was used, the descriptors were “Irritable bowel syndrome” AND “COVID-19”; the reference list of the articles was also retrieved. Results: eight studies were reviewed, it was observed that 0.6% to 11.6% of patients had IBS again after a minimum period of 6 months of infection. Risk factors were female gender, severity of COVID-19, presence of acute-phase gastrointestinal symptoms, and depression/anxiety. Conclusion: the results obtained suggest that COVID-19 may be associated with the emergence of de novo IBS. Further studies are needed to investigate its long-term effects and clinical spectra.Keywords
This publication has 26 references indexed in Scilit:
- Post-acute COVID-19 syndromeNature Medicine, 2021
- Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global StudyGastroenterology, 2021
- ACE2: The Major Cell Entry Receptor for SARS-CoV-2Lung, 2020
- COVID-19 pathophysiology: A reviewClinical Immunology, 2020
- Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter StudyAmerican Journal of Gastroenterology, 2020
- Rome Foundation Working Team Report on Post-Infection Irritable Bowel SyndromeGastroenterology, 2019
- What Is New in Rome IVJournal of Neurogastroenterology and Motility, 2017
- Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysisGastroenterology, 2017
- Integrative review: what is it? How to do it?Einstein (São Paulo), 2010
- THE IRRITABLE COLON SYNDROMEA Study of the Clinical Features, Predisposing Causes, and Prognosis in 130 CasesQJM: An International Journal of Medicine, 1962